Blue Shield of California Addresses Barriers to Language and Care with New Digital Tools

News
Article

Digital health platform Wellvolution adds Spanish webpage and an at-home hypertension tracking feature.

© 9dreamstudio- stock.adobe.com

family insurance © 9dreamstudio- stock.adobe.com

Blue Shield of California’s digital health platform Wellvolution has added a webpage option in Spanish, as well as Dario, an at-home solution for hypertension.

Over 148,000 Blue Shield of California members use Wellvolution, which is a supplemental, free healthcare program members can use to help stay on track.

Members can now sign up, select their health goal, complete a health questionnaire, and receive personalized program recommendations - all in Spanish.

Over a quarter of Californians speak Spanish at home and research shows Hispanic communities are more likely to have trouble accessing health services than other groups because of language barriers.

Dario is another new feature also available in Spanish at no extra cost to members. The program gathers information from patients’ Bluetooth-enabled blood pressure monitors and a health care coach provides personalized advice through the app. Research shows that 71% of Dario users saw improvements within the first three months which is promising for the 30% of Californians who have hypertension.

Spanish-speaking members can visit Wellvolution.com/es to enroll in Wellvolution or to get started with Dario.

Recent Videos
Video 8 - "Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization"
Video 7 - "Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider"
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Video 6 - "Developing Reimbursement Models for Digital Therapeutics"
Related Content
© 2024 MJH Life Sciences

All rights reserved.